Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance
Acquisition Strengthens Existing Pipeline in Viral Diseases
NEW BRUNSWICK, N.J., Sept.
Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market
Ventana is committed to accelerating the discovery and development of new cancer diagnostic tests that help determine the best course of therapy for each individual patient.
Prospects For Leading Players
NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Report Details
MSF URGES PRIME MINISTER MODI TO RESIST U.S. POLITICAL PRESSURE TO RESTRICT GLOBAL ACCESS TO MEDICINES
FDA Approves RELISTOR® Subcutaneous Injection for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-cancer Pain
INDIANAPOLIS, Sept. 29, 2014 /PRNewswire/ -- On Oct.
The Ohio State University Issues Purchase Order For Lab Supplies To NanoLogix